UBS Group’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-110
| Closed | -$286 | – | 9118 |
|
|
2024
Q1 | $286 | Buy |
110
+108
| +5,400% | +$281 | ﹤0.01% | 7485 |
|
|
2023
Q4 | $7 | Hold |
2
| – | – | ﹤0.01% | 7928 |
|
|
2023
Q3 | $10 | Sell |
2
-541
| -100% | -$2.71K | ﹤0.01% | 8075 |
|
|
2023
Q2 | $4.63K | Buy |
543
+541
| +27,050% | +$4.62K | ﹤0.01% | 6432 |
|
|
2023
Q1 | $25 | Sell |
2
-5
| -71% | -$63 | ﹤0.01% | 8304 |
|
|
2022
Q4 | $107 | Hold |
7
| – | – | ﹤0.01% | 9196 |
|
|
2022
Q3 | $0 | Sell |
7
-112
| -94% | – | ﹤0.01% | 10123 |
|
|
2022
Q2 | $11K | Buy |
119
+79
| +198% | +$7.3K | ﹤0.01% | 6864 |
|
|
2022
Q1 | $6K | Sell |
40
-133
| -77% | -$20K | ﹤0.01% | 7983 |
|
|
2021
Q4 | $52K | Buy |
173
+120
| +226% | +$36.1K | ﹤0.01% | 5770 |
|
|
2021
Q3 | $21K | Buy |
53
+30
| +130% | +$11.9K | ﹤0.01% | 5999 |
|
|
2021
Q2 | $10K | Buy |
+23
| New | +$10K | ﹤0.01% | 6980 |
|